Stocks Comparison
DocGo vs InnovAge: revenue, profit, margins and growth compared
DocGo brought in $322.2M of revenue in fiscal 2025, InnovAge $989.7M in fiscal 2026. Revenue changed by -47.7% at DocGo and +15.9% at InnovAge on the year before, so InnovAge grew faster. DocGo kept -56.6% of its revenue as net profit, InnovAge -0.3%. Free cash flow was $29.9M at DocGo and $50.4M at InnovAge.
Side by side, latest fiscal year
| DCGO | INNV | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2026 (June 30, 2026) |
| Revenue | $322.2M | $989.7M |
| Revenue growth | -47.7% | +15.9% |
| Net income | -$182.4M | -$2.5M |
| Net margin | -56.6% | -0.3% |
| Free cash flow | $29.9M | $50.4M |
| Free cash flow margin | 9.3% | 5.1% |
| Earnings per share (diluted) | -$1.84 | -$0.02 |
| Cash | $51M | $97.9M |
| Debt | $235.6K | $48.8M |
| Price to earnings | n/a | n/a |
| Market value | $34.1M | $1.2B |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #217 of 523 · Health care | #145 of 523 · Health care |
Over the years
Questions about DocGo and InnovAge
Which is bigger by revenue, DocGo or InnovAge?
InnovAge is bigger by revenue: $989.7M in fiscal 2026, against $322.2M for DocGo in fiscal 2025.
Which keeps more of its revenue as profit, DocGo or InnovAge?
DocGo had a net margin of -56.6% in fiscal 2025; InnovAge had -0.3% in fiscal 2026.
Which grew revenue faster, DocGo or InnovAge?
In their latest fiscal years revenue changed by -47.7% at DocGo and +15.9% at InnovAge.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.